Magnetic resonance imaging in acute stroke: Not ready for prime time

Neurology

Volumn 50, Issue 4, 1998, Pages 842-843

  Powers, William J ^a   Zivin, Justin ^a  

^a UNIVERSITY OF CALIFORNIA   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ACUTE DISEASE; CEREBROVASCULAR DISEASE; HUMAN; METHODOLOGY; NOTE; NUCLEAR MAGNETIC RESONANCE IMAGING; PREDICTION AND FORECASTING; STANDARD;

ACUTE DISEASE; CEREBROVASCULAR DISORDERS; HUMANS; MAGNETIC RESONANCE IMAGING; PREDICTIVE VALUE OF TESTS;

EID: 0032042322     PISSN: 00283878     EISSN: 1526632X     Source Type: Journal    
DOI: 10.1212/WNL.50.4.842     Document Type: Editorial

References (17)

1. Tong DC, Yenari MA, Albers GW, O'Brien M, Marks MP, Moseley ME. Correlation of perfusion and diffusion weighted MRI with NIH SS score in acute ischemic stroke. Neurology 1998;50:864-870.
2. Takano K, Carano RAD, Tatlisumak T, et al. Efficacy of intra-arterial and intravenous prourokinase in an embolic stroke model evaluated by diffusion-perfusion MRI. Neurology 1998;50:870-875.
3. Kent DL, Haynor DR, Longstreth WT Jr, Larson EB. The clinical efficacy of magnetic resonance imaging in neuroimaging. Ann Intern Med 1994;120:856-871.
4. Siegel JE, Weinstein MC, Russell LB, Gold MR. Recommendations for reporting cost-effectiveness analysis. JAMA 1996;276:1339-1341.
5. Kothari RU, Brott T, Broderick JP, Hamilton CA. Emergency physicians' accuracy in the diagnosis of stroke. Stroke 1995;26:2238-2241.
6. Libman RB, Wirkowski E, Alvir J, Rao TH. Conditions that mimic stroke in the emergency department. Arch Neurol 1995;52:1119-1122.
7. Hasegawa Y, Formato JE, Latour LL, et al. Severe transient hypoglycemia causes reversible change in the apparent diffusion coefficient of water. Stroke 1996;27:1648-1655.
8. Zhong J, Petroff OA, Prichard JW, Gore JC. Barbiturate-reversible reduction of water diffusion coefficient in fluoroethyl-induced status epilepticus in rats. Magn Reson Med 1995;33:253-256.
9. Reid MC, Lachs MS, Feinstein AR. Use of methodological standards in diagnostic test research-Getting better but still not good. JAMA 1995;274:645-651.
10. Powers WJ, Berg L, Perlmutter JS, Raichle ME. Technology assessment revisited: does positron emission tomography have proven clinical utility? Neurology 1991;41:1339-1340.
11. Furlan AJ, Kanoti G. When is thrombolysis justified in patients with acute ischemic stroke? A bioethical perspective. Stroke 1996;28:214-218.
12. Caplan LR, Mohr JP, Kistler JP, Koroshetz W. Thrombolysis-not a panacea for ischemic stroke. N Engl J Med 1997;337:1309-1310.
13. Grotta J. Should thrombolytic therapy be the first-line treatment for acute ischemic stroke? N Engl J Med 1997;337:1310-1313.
14. NINDS t-PA Stroke Study Group. Generalized efficacy of t-PA for acute stroke-Subgroup analysis of the NINDS t-PA Stroke Trial. Stroke 1997;28:2119-2125.
15. Powers WJ. Hemodynamics and metabolism in ischemic cerebrovascular disease. Neurologic Clinics 1992;10:31-48.
16. Furlan M, Marchal M, Viader F, Derlon J-M, Baron J-C. Spontaneous neurological recovery after stroke and the fate of the ischemic penumbra. Ann Neurol 1996;40:216-226.
17. Ewigman BG, Crane JP, Frigoletto FD, LeFevre ML, Bain RP, McNellis D. Effect of prenatal ultrasound screening on perinatal outcome. N Engl J Med 1993;329:821-827.